Predict your next investment

HEALTHCARE | Medical Facilities & Services / Medical Laboratories & Research
aragenbio.com

See what CB Insights has to offer

Total Raised

$2.72M

Investors Count

1

Deal Terms

1

Aragen Bioscience Funding, Aragen Bioscience Valuation & Aragen Bioscience Revenue

2 Fundings

Aragen Bioscience's latest funding round was a Acquired for on January 29, 2014.

Date

Round

Amount

Investors

Valuation
Valuations are submitted by companies, mined from state filings or news, provided by VentureSource, or based on a comparables valuation model.

Revenue

Sources

1/29/2014

Acquired

Aragen Life Sciences

$0.00B

((9.99x))

FY 1234

1

1/28/2014

Series B

$99M

$0.00B

((9.99x))

FY 1234

10

Date

1/29/2014

1/28/2014

Round

Acquired

Series B

Amount

$99M

Investors

Aragen Life Sciences

Valuation

Revenue

$0.00B

((9.99x))

FY 1234

$0.00B

((9.99x))

FY 1234

Sources

1

10

Aragen Bioscience Deal Terms

1 Deal Term

Aragen Bioscience's deal structure is available for 1 funding round, including their Series B from January 28, 2014.

Round

Series B

Funding Date

Pre-Money Valuation

Post-Money Valuation

Amount Raised

Shares Authorized

Issuance Price

Dividend Rate

Liquidation Preferences

Liquidation Price

Participation

Conversion Price

Anti Dilution

General Voting

Board Voting

Par Value

Round

Funding Date

Pre-Money Valuation

Post-Money Valuation

Amount Raised

Shares Authorized

Issuance Price

Dividend Rate

Liquidation Preferences

Liquidation Price

Participation

Conversion Price

Anti Dilution

General Voting

Board Voting

Par Value

Series B

Aragen Bioscience Investors

1 Investors

Aragen Bioscience has 1 investors. Aragen Life Sciences invested in Aragen Bioscience's Acquired funding round.

First funding

Last Funding

Investor

Rounds

Board Seats

Type

Location

1/29/2014

1/29/2014

1
Acquired

Corporation

California

First funding

1/29/2014

Last Funding

1/29/2014

Investor

Rounds

1
Acquired

Board Seats

Type

Corporation

Location

California

CB Insights uses Cookies

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.